[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544781":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":19,"interventions":25,"overallOfficials":30,"centralContacts":34,"locations":39,"responsibleParty":58,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":13,"eligibilityCriteria":69,"healthyVolunteers":66,"sex":70,"minAge":13,"maxAge":13,"enrollmentInfo":71,"targetDuration":13,"studyType":74,"phases":13,"briefSummary":75,"conditions":76,"keywords":13,"overallStatus":42,"whyStopped":13,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Safety and adverse events (AEs)","ncidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events","Through study completion; an average of 1 year",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"CASE_ONLY","PROSPECTIVE","Primary Objectives\n\n\\- The primary objective of this proposed study is to show that bWBT (B.brilliant wide-angle breast tomosynthesis) images provide better lesion conspicuity for masses and architectural distortions than NBT images based on the standard screening tomosynthesis imaging.\n\nSecondary Objectives\n\n* The secondary objective of this proposed study is to show that WBT images provide better lesion conspicuity for masses and architectural distortions based on the standard screening tomosynthesis imaging.\n* Additional secondary objectives include radiologist feedback on the B.brilliant images, technologist experience with B.brilliant, and a participant comfort survey.","Screening mammography population at MD Anderson",[20],{"label":21,"type":13,"description":22,"interventionNames":23},"Digital Breast Tomosynthesis (DBT)","Participants that agree to take part in this study, your standard follow-up imaging will be done using an FDA approved DBT system, but it will be different from the DBT system used for your routine screening. For example, if narrow-angle DBT was used for your routine screening, then you will have standard wide-angle DBT. If wide-angle DBT used for your routine screening, then you will have narrow-angle DBT. These images will be used for diagnosis and to help decide your further care.",[24],"Device: Digital Breast Tomosynthesis (DBT)",[26],{"type":27,"name":21,"description":28,"armGroupLabels":29,"otherNames":13},"DEVICE","Undergo tomosynthesis imaging",[21],[31],{"name":32,"affiliation":5,"role":33},"Beatriz Adrada, MD","PRINCIPAL_INVESTIGATOR",[35],{"name":32,"role":36,"phone":37,"phoneExt":13,"email":38},"CONTACT","(713) 792-2709","beatriz.adrada@mdanderson.org",[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"MD Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-95.36327,29.76328,{"lat":52,"lon":51},[55,57],{"name":32,"role":36,"phone":56,"phoneExt":13,"email":38},"713-792-2709",{"name":32,"role":33,"phone":13,"phoneExt":13,"email":13},{"type":59,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR",[61],{"name":62,"class":63},"Siemens Medical Solutions","INDUSTRY","100544781","comparison-of-conspicuity-of-masses-and-architectural-distortions-between-wide--and-narrow-angle-digital-breast-tomosynthesis-systems-100544781",false,"NCT06373354","Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems","Inclusion Criteria:\n\n* Women undergoing standard screening mammography.\n* Ability to understand and sign consent.\n\nExclusion Criteria:\n\n* Pregnant women.\n* Women unable to consent.\n* Male patients.","FEMALE",{"count":72,"type":73},100,"ESTIMATED","OBSERVATIONAL","To compare narrow-angle digital breast tomosynthesis (DBT) and wide-angle DBT.",[77,78],"Architectural Distortions","Breast Tomosynthesis","2026-10-06",{"date":81,"type":82},"2026-10-07","ACTUAL",{"date":84,"type":82},"2024-10-18",{"date":86,"type":73},"2027-12-31",{"name":5,"class":6},1]